Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

ETR/TN8 stock hub

ETR/TN8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/TN8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

146.8B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/TN8

In the news

Latest news · ETR/TN8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.2

P25 12.3P50 15.7P75 20.2

Trailing P/E24.7

P25 16.4P50 20.9P75 30.4

ROE13.5

P25 -6.7P50 8.5P75 17.2

ROIC9

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/TN8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	125,000
Employees Change	3,000%
Employees Change Percent	2.46
Enterprise value	EUR 180.8B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	US8835561023
Last refreshed	2026-05-10
Market cap	EUR 146.8B
Price	EUR 393
Price currency	EUR
Rev Per Employee	313,847.97x
Sector	Healthcare
Sic	3826
Symbol	etr/TN8
Website	https://www.thermofisher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.05%
EV Earnings	30.42x
EV/EBIT	25.18x
EV/EBITDA	18.1x
EV/FCF	30.87x
EV/Sales	4.71x
FCF yield	3.99%
Forward P/E	18.21x
P/B ratio	3.25x
P/E ratio	24.7x
P/S ratio	3.74x
PE Ratio10 Y	31.53x
PE Ratio3 Y	31.69x
PE Ratio5 Y	30.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.78%
EBITDA Margin	24.99%
FCF margin	14.93%
Gross margin	40.93%
Gross Profit	EUR 16.1B
Gross Profit Growth	4.08%
Gross Profit Growth Q	4.66%
Gross Profit Growth3 Y	1.51%
Gross Profit Growth5 Y	0.02%
Net Income	EUR 5.9B
Net Income Growth	5.13%
Net Income Growth Q	9.56%
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth3 Y	4.37%
Net Income Growth5 Y	-2.88%
Pretax Margin	16.35%
Profit Margin	15.15%
Profit Per Employee	EUR 47,553
Profitable Years	24
ROA	5
Roa5y	5.62
ROCE	8.6
ROE	13.52
Roe5y	15.21
ROIC	8.95
Roic5y	10.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.5%
Cagr3y	-7.1%
Cagr5y	0.38%
Div CAGR3	8.15%
Div CAGR5	12.5%
EPS Growth	6.67
EPS Growth Q	11.31
EPS Growth Quarters	6
EPS Growth Years	2
EPS Growth3 Y	5.84
EPS Growth5 Y	-1.75
FCF Growth	0.36%
FCF Growth Q	126.04%
FCF Growth3 Y	6.29%
FCF Growth5 Y	-3.5%
OCF Growth	1.82%
OCF Growth Q	64.87%
OCF Growth10 Y	10.43%
OCF Growth3 Y	2.56%
OCF Growth5 Y	-3.52%
Revenue Growth	5.36x
Revenue Growth Q	6.19x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	1.05x
Revenue Growth5 Y	4.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.43
Assets	EUR 98.3B
Cash	EUR 2.8B
Current Assets	EUR 18.9B
Current Liabilities	EUR 12.4B
Debt	EUR 37.5B
Debt EBITDA	EUR 3.66
Debt Equity	EUR 0.83
Debt FCF	EUR 6.4
Equity	EUR 45.2B
Interest Coverage	5.77
Liabilities	EUR 53.1B
Long Term Assets	EUR 79.4B
Long Term Liabilities	EUR 40.7B
Net Cash	EUR -34.6B
Net Cash By Market Cap	EUR -23.59
Net Debt EBITDA	EUR 3.53
Net Debt Equity	EUR 0.77
Net Debt FCF	EUR 5.91
Tangible Book Value	EUR -19.4B
Tangible Book Value Per Share	EUR -52.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.53
Inventory Turnover	4.98
Net Working Capital	EUR 6.5B
Quick ratio	0.97
Working Capital	EUR 6.7B
Working Capital Turnover	EUR 4.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.38%
Dividend Growth	1.96%
Dividend Growth Years	7%
Dividend per share	EUR 1.51
Dividend Years	7
Dividend Yield	0.39%
Ex Div Date	2026-03-13
Last Dividend	EUR 0.41
Payout Frequency	Quarterly
Payout Ratio	9.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.49%
200-day SMA	451.7
3Y total return	-19.84%
50-day SMA	421.5
50-day SMA vs 200-day SMA	50under200
5Y total return	1.91%
All Time High	605.9
All Time High Change	-35.15%
All Time High Date	2022-08-16
All Time Low	336.3
All Time Low Change	16.85%
All Time Low Date	2025-06-18
ATR	11.1
Ch YTD	-20.46
High	406.4
High52	548.9
High52 Date	2026-01-23
High52ch	-28.42%
Low	389.5
Low52	336.3
Low52 Date	2025-06-18
Low52ch	16.85%
Ma50ch	-6.79%
Price vs 200-day SMA	-13.01%
RSI	36.63
RSI Monthly	41.11
RSI Weekly	37.08
Sharpe ratio	0.31x
Sortino ratio	0.64
Total Return	1.76%
Tr YTD	-20.38
Tr1m	-5.55%
Tr1w	-1.11%
Tr3m	-14.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 7.4B
Operating Income Growth	8.22
Operating Income Growth Q	7.01
Operating Income Growth3 Y	4.42
Operating Income Growth5 Y	-3.25
Operating margin	18.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	370,687,718%
Net Borrowing	6,410,592,720
Shares Insiders	0.13%
Shares Institutions	93.63%
Shares Qo Q	-1.06%
Shares Yo Y	-1.38%
Short Ratio	2.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 5.6B
Average Volume	262.7x
Bv Per Share	121.3
CAPEX	EUR -1.3B
Ch1m	-5.55
Ch1w	-1.11
Ch1y	9.09
Ch3m	-14.36
Ch3y	-20.58
Ch5y	0.54
Ch6m	-20.88
Change	-2.39%
Change From Open	-3.01
Close	402.5
Days Gap	0.65
Depreciation Amortization	2,381,925,258
Dollar Volume	73,079.4
Earnings Date	2026-04-23
EBIT	EUR 7.4B
EBITDA	EUR 9.8B
EPS	EUR 15.79
F Score	4
FCF	EUR 5.9B
FCF EV Yield	3.24x
Financing CF	2,600,528,000
Fiscal Year End	December
Founded	1,956
Goodwill	46,796,478,894
Graham Number	208.04968
Graham Upside	-47.05
Income Tax	EUR 453.1M
Investing CF	-10,833,508,000
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-28
Lynch Fair Value	EUR 79.54
Lynch Upside	-79.76
Ma150	465.6
Ma150ch	-15.61%
Ma20	418.8
Ma20ch	-6.19%
Net CF	-774,256,000
Open	405.1
P FCF Ratio	25.07
P OCF Ratio	20.41
Payment Date	2026-04-15
Position In Range	20.12
Ppne	9,037,578,996
Price Date	2026-05-08
Price EBITDA	EUR 14.97
Relative Volume	0.73x
Revenue	39,230,996,000x
SBC By Revenue	0.7x
Share Based Comp	276,024,000
Tax By Revenue	1.15x
Tax Rate	7.07%
Tr6m	-20.74%
Volume	186
Z Score	3.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/TN8 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$1.51 annual per share

Payout ratio

+9.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.5%

7 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2026-03-13

Performance

ETR/TN8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/TN8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+93.6%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/TN8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.6

Neutral momentum band

Price vs 200-day MA

-13.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/TN8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/TN8 stock rating?

etr/TN8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/TN8 analysis?

The full report lives at /stocks/etr/TN8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/TN8?

The latest report frames etr/TN8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/TN8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.